Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.

por Gora-Tybor, Joanna, Blonski, Jerzy Z, Robak, Tadeusz
Publicado 2003

Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors

por Kubczak, Małgorzata, Szustka, Aleksandra, Błoński, Jerzy Z., Gucký, Tomaš, Misiewicz, Małgorzata, Krystof, Vladmir, Robak, Paweł, Rogalińska, Małgorzata
Publicado 2019

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development

por Rogalińska, Małgorzata, Góralski, Paweł, Błoński, Jerzy Z., Robak, Paweł, Barciszewski, Jan, Koceva-Chyła, Aneta, Piekarski, Henryk, Robak, Tadeusz, Kilianska, Zofia M.
Publicado 2017